Filing Details
- Accession Number:
- 0001140361-16-085046
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-11-07 14:20:56
- Reporting Period:
- 2016-11-03
- Filing Date:
- 2016-11-07
- Accepted Time:
- 2016-11-07 14:20:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1335103 | Protea Biosciences Group Inc. | PRGB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529364 | Stanley Hostler | 1311 Pineview Drive, Suite 501 Morgantown WV 26505 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-11-03 | 293,333 | $0.08 | 2,724,992 | No | 4 | P | Indirect | By spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By spouse |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Class A Warrant to Purchase Common Stock | Acquisiton | 2016-11-03 | 293,333 | $0.08 | 293,333 | $0.09 |
Common Stock | Class B Warrant to Purchase Common Stock | Acquisiton | 2016-11-03 | 293,333 | $0.08 | 293,333 | $0.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
293,333 | 2016-11-03 | 2017-05-03 | No | 4 | A | Indirect |
293,333 | 2016-11-03 | 2021-11-03 | No | 4 | A | Indirect |
Footnotes
- The spouse of Reporting Person purchased 2.2 Units of the Issuer's securities for an aggregate purchase price of $22,000, each Unit consisting of (a) 133,333.33 shares of common stock, par value $0.0001 per share (the "Common Stock"), (b) 18 month warrants to purchase up to 133,333.33 shares of Common Stock at an exercise price of $0.09 per share (the "Class A Warrants"), and (c) five year warrants to purchase up to 133,333.33 shares of Common Stock at an exercise price of $0.1125 per share (the "Class B Warrants").